We are live on ! Find out more
FMTX

Forma Therapeutics Holdings, Inc. Common Stock
FMTX

Delisted

FMTX was delisted on the 13th of October, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in Forma Therapeutics Holdings, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 137 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 139 → 0 (-139)

100% less funds holding in top 10

Funds holding in top 10: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $835M → $0 (-$835M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 137

Holders
–
Holders Change
-139
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
137
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$180M
2
BlackRock
BlackRock
New York
-$72.5M
3
BBA
Baker Bros. Advisors
New York
-$37.6M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$37.2M
5
TAL
TIG Advisors LLC
New York
-$26.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
26
AQR Arbitrage
Connecticut
– -$6.57M -329,444 Closed
Goldman Sachs
27
Goldman Sachs
New York
– -$6.42M -321,553 Closed
GLAM
28
Gardner Lewis Asset Management
Pennsylvania
– -$6.38M -320,000 Closed
E
29
Ergoteles
New York
– -$5.98M -299,584 Closed
Bank of America
30
Bank of America
North Carolina
– -$5.8M -290,617 Closed
Wellington Management Group
31
Wellington Management Group
Massachusetts
– -$5.59M -280,183 Closed
Charles Schwab
32
Charles Schwab
California
– -$5.47M -274,027 Closed
EFI
33
EHP Funds Inc
Canada
– -$4.99M -250,000 Closed
KC
34
Kryger Capital
United Kingdom
– -$4.85M -243,303 Closed
Dimensional Fund Advisors
35
Dimensional Fund Advisors
Texas
– -$4.79M -239,874 Closed
GF
36
Gabelli Funds
New York
– -$4.66M -233,414 Closed
UBS Group
37
UBS Group
Switzerland
– -$4.44M -222,712 Closed
MF
38
Magnetar Financial
Illinois
– -$4.4M -220,726 Closed
Qube Research & Technologies (QRT)
39
Qube Research & Technologies (QRT)
United Kingdom
– -$4.02M -201,587 Closed
N
40
Nuveen
North Carolina
– -$4.01M -200,901 Closed
MS
41
Maven Securities
Jersey
– -$3.99M -200,000 Closed
MAM
42
Miria Asset Management
Malta
– -$3.49M -174,900 Closed
PCM
43
Prelude Capital Management
New York
– -$3.42M -171,295 Closed
YCM
44
Yakira Capital Management
Connecticut
– -$3.29M -164,805 Closed
KCM
45
Kennedy Capital Management
Missouri
– -$3.06M -153,555 Closed
BC
46
Brookfield Corp
Ontario, Canada
– -$2.99M -150,100 Closed
DAM
47
DLD Asset Management
New York
– -$2.99M -150,000 Closed
GCIA
48
Gabelli & Co Investment Advisers
New York
– -$2.96M -148,550 Closed
Prudential Financial
49
Prudential Financial
New Jersey
– -$2.9M -145,435 Closed
Bank of New York Mellon
50
Bank of New York Mellon
New York
– -$2.51M -125,574 Closed
1
2
3 4 5

FMTX Hedge Fund Activity: Q4 2022 in Review

0 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Forma Therapeutics Holdings, Inc. Common Stock (FMTX) for Q4 2022, worth a combined $0 — down 100% from $835M a quarter earlier.

Sellers outnumbered buyers: 137 funds closed out of FMTX and 0 opened new positions — a net loss of 137 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RA Capital Management, exiting entirely with an estimated $180M sold.

  • 0 institutional investors held Forma Therapeutics Holdings, Inc. Common Stock (FMTX) as of Q4 2022, down from 139 in Q3 2022.
  • Funds reported $0 of Forma Therapeutics Holdings, Inc. Common Stock stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Forma Therapeutics Holdings, Inc. Common Stock positions in Q4 2022 and 137 closed out, a net change of -137 holders.
  • The largest Forma Therapeutics Holdings, Inc. Common Stock seller in Q4 2022 was RA Capital Management, an estimated $180M sold.

Based on aggregated 13F filings for Q4 2022.